Discovery of Novel Sesquistilbene Indanone Analogues As Potent Anti-inflammatory Agents
Overview
Affiliations
To develop novel anti-inflammatory agents with improved pharmaceutical profiles, twenty-eight novel sesquistilbene indanone analogues were synthesized and evaluated for anti-inflammatory activity using RAW264.7 cells. Among these compounds, compound 11k was found to be one of the most potent analogues in inhibiting NO production in LPS-stimulated RAW264.7 cells. Furthermore, it could also significantly suppress LPS-induced iNOS and COX-2 expression and NO production through TLR4/JNK/NF-κB signaling pathway in a concentration dependent manner.
Khadem Sadigh M, Sayyar Z, Shamkhali A, Teimuri-Mofrad R, Rahimpour K Sci Rep. 2024; 14(1):26559.
PMID: 39489809 PMC: 11532497. DOI: 10.1038/s41598-024-78194-9.
and insights into tyrosinase inhibitors with ()-benzylidene-1-indanone derivatives.
Jin Jung H, Noh S, Park Y, Kang D, Chun P, Young Chung H Comput Struct Biotechnol J. 2020; 17:1255-1264.
PMID: 31921392 PMC: 6944710. DOI: 10.1016/j.csbj.2019.07.017.
Shen Q, Gong G, Li G, Jin M, Cao L, Quan Z J Enzyme Inhib Med Chem. 2019; 35(1):85-95.
PMID: 31707866 PMC: 6853232. DOI: 10.1080/14756366.2019.1680658.
Zhang Y, Zheng Y, Shi W, Guo Y, Xu T, Li Z Molecules. 2019; 24(20).
PMID: 31614601 PMC: 6832651. DOI: 10.3390/molecules24203663.
Xiao S, Zhang W, Chen H, Fang B, Qiu Y, Chen X Drug Des Devel Ther. 2018; 12:887-899.
PMID: 29719375 PMC: 5914570. DOI: 10.2147/DDDT.S160314.